Nakatani, Yukihiro
Kato, Ken http://orcid.org/0000-0002-1733-5072
Shoji, Hirokazu
Iwasa, Satoru
Honma, Yoshitaka
Takashima, Atsuo
Ushijima, Toshikazu
Ito, Yoshinori
Itami, Jun
Boku, Narikazu
Funding for this research was provided by:
National Cancer Center Research and Development Fund (29-A-3)
Article History
Received: 11 October 2019
Accepted: 3 March 2020
First Online: 18 March 2020
Compliance with ethical standards
:
: Ken Kato received honoraria from Eli Lilly and Beigene; and research funding from ONO, MSD, Merck Serono and Shionogi Co and Ltd. Narikazu Boku received honoraria from Taiho, Chugai, Eli Lilly, Ono and BMS; and research funding from Taiho and Ono. YN, HS, SI, YN, AT, TU, YI and JI report no potential conflicts of interest.